Tuesday, 02 January 2024 12:17 GMT

Disposable Bronchoscope Market Projected To Reach $704.0 Million By 2030, Driven By Rising Respiratory Disease Prevalence And Demand For Minimally Invasive Procedures - 2024 Research


(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Disposable Bronchoscope Market Size, Share & Trends Analysis Report By Usage, By Indication, sBy Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.

Market Expansion Catalyzed by Advancements in Respiratory Disease Treatments
The disposable bronchoscope market is anticipated to witness substantial growth, with expectations to ascend to USD 704.0 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.7% from 2025 to 2030. This growth is underpinned by the increasing global incidence of chronic respiratory disorders including COPD, lung stenosis, lung cancer, and infections, which call for enhanced bronchoscopy techniques.
Trend towards Outpatient Procedures Bolsters Market Dynamics
Leveraging advancements in health care technology, the market is observing a shift toward same-day surgeries and minimally invasive procedures, reducing hospital stays and expediting patient recovery. Outpatient facilities have predominantly contributed to the market share due to their emphasis on patient safety and preference for disposable bronchoscopes to prevent infection risks.
Geographical Landscape Showcasing North America's Dominance and Asia Pacific's Rapid Growth
North America is at the forefront of the market, attributed to its state-of-the-art healthcare infrastructure, swift adoption of new technologies, and inclination towards minimally invasive medical interventions. Concurrently, the Asia Pacific region is poised for the most expeditious growth during the forecast period, with factors such as healthcare infrastructure enhancements, economic progress, an aging population, and the rising incidence of lung cancers and COPD fueling the region's market proliferation.
Strategic Insights for Stakeholders and Anticipated Market Trajectories
Stakeholders within the disposable bronchoscope space can anticipate a comprehensive understanding of the market dynamics and trends, ensuring their strategic alignment with the evolving healthcare landscape. The increasing clinical urgency for disposable bronchoscopes in the accurate detection and treatment of lung-related ailments is a potent driver of market expansion.
The report provides insightful analysis of the global market trends, taking into account the impacts of the recent COVID-19 pandemic, and offers actionable recommendations for organizations to navigate through the evolving markets effectively. It encompasses detailed forecasts, competitive landscape assessment, and acknowledges the significant growth opportunities within the sector.
This growth narrative within the disposable bronchoscope market reflects the medical community's ongoing commitment to enhancing patient outcomes through technological innovation and the focused response to the increasing burden of respiratory diseases on global health systems.
Key Attributes:

Report Attribute Details
No. of Pages 100
Forecast Period 2024 - 2030
Estimated Market Value (USD) in 2024 $428.1 million
Forecasted Market Value (USD) by 2030 $704 million
Compound Annual Growth Rate 8.7%
Regions Covered Global


Companies Featured

  • Olympus Corporation
  • NeoScope, Inc.
  • FUJIFILM Holdings Corporation
  • Stryker Corporation
  • Boston Scientific Corporation
  • Karl Storz GmbH & Co. KG
  • Smith & Nephew Inc.
  • Richard Wolf GmbH
  • PENTAX Medical
  • AMBU A/S


For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • Disposable Bronchoscope Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN15012025004107003653ID1109094182



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search